Biotech startups face ‘Series A cliff’ as venture capital stays cautious
Bio Pharma Dive
MARCH 24, 2023
Series A rounds have been easy to secure in the last few years, but industry watchers say they haven't seen a corresponding increase in Series B's as startups struggle to recruit new investors
Let's personalize your content